PL321239A1 - Mutations of proteins - Google Patents
Mutations of proteinsInfo
- Publication number
- PL321239A1 PL321239A1 PL96321239A PL32123996A PL321239A1 PL 321239 A1 PL321239 A1 PL 321239A1 PL 96321239 A PL96321239 A PL 96321239A PL 32123996 A PL32123996 A PL 32123996A PL 321239 A1 PL321239 A1 PL 321239A1
- Authority
- PL
- Poland
- Prior art keywords
- mutations
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9502771.0A GB9502771D0 (en) | 1995-02-13 | 1995-02-13 | Organic compounds |
GBGB9513505.9A GB9513505D0 (en) | 1995-07-03 | 1995-07-03 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PL321239A1 true PL321239A1 (en) | 1997-11-24 |
Family
ID=26306494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL96321239A PL321239A1 (en) | 1995-02-13 | 1996-02-12 | Mutations of proteins |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0811060A1 (xx) |
JP (1) | JPH10509327A (xx) |
KR (1) | KR19980702160A (xx) |
CN (1) | CN1173897A (xx) |
AU (1) | AU4665196A (xx) |
BR (1) | BR9606951A (xx) |
CA (1) | CA2210538A1 (xx) |
CZ (1) | CZ255397A3 (xx) |
FI (1) | FI972763A (xx) |
HU (1) | HUP9801681A3 (xx) |
IL (1) | IL117113A0 (xx) |
NO (1) | NO973679L (xx) |
PL (1) | PL321239A1 (xx) |
SK (1) | SK109997A3 (xx) |
WO (1) | WO1996025492A1 (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999001551A2 (en) * | 1997-06-30 | 1999-01-14 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel inhibitor of cellular proliferation |
US7166467B2 (en) | 2001-07-23 | 2007-01-23 | Senesco Technologies, Inc. | Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
US7968523B2 (en) | 2001-07-23 | 2011-06-28 | Senesco Technologies, Inc. | Method for inducing apoptosis using apoptosis-specific EIF5-A |
US7381708B2 (en) | 2001-07-23 | 2008-06-03 | Sensco Technologies, Inc. | Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye |
US6867237B1 (en) * | 2001-07-23 | 2005-03-15 | Senesco Technologies, Inc. | DNA encoding apoptosis-induced eucaryotic initiation factor-5A and deoxyhypusine synthase and a method for controlling apoptosis in animals and humans |
US7217517B2 (en) * | 2001-07-23 | 2007-05-15 | Senesco Technologies, Inc. | Nucleic acids, polypeptides, and methods for modulating apoptosis |
TW200427695A (en) | 2003-03-05 | 2004-12-16 | Senesco Technologies Inc | Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1 |
EP1636364A2 (en) * | 2003-06-06 | 2006-03-22 | Senesco Technologies, Inc. | INHIBITION OF APOPTOSIS-SPECIFIC ELF-5A ( EIF-5A1) WITH ANTISENSE OLIGONUCLEOTIDES AND siRNAs AS ANTI-INFLAMMATORY THERAPEUTICS |
EP2265717A4 (en) | 2008-03-07 | 2012-09-12 | Senesco Technologies Inc | USE OF RNSI TO OBTAIN NEGATIVE REGULATION OF ENDOGENOUS GENE IN COMBINATION WITH THE USE OF SENS BUILDING PRODUCT TO OBTAIN EXPRESSION OF DESIRED POLYNUCLEOTIDE |
US8445638B2 (en) | 2008-09-03 | 2013-05-21 | Senesco Technologies, Inc. | Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells |
-
1996
- 1996-02-12 HU HU9801681A patent/HUP9801681A3/hu unknown
- 1996-02-12 AU AU46651/96A patent/AU4665196A/en not_active Abandoned
- 1996-02-12 WO PCT/EP1996/000585 patent/WO1996025492A1/en not_active Application Discontinuation
- 1996-02-12 SK SK1099-97A patent/SK109997A3/sk unknown
- 1996-02-12 PL PL96321239A patent/PL321239A1/xx unknown
- 1996-02-12 EP EP96902265A patent/EP0811060A1/en not_active Withdrawn
- 1996-02-12 JP JP8524649A patent/JPH10509327A/ja active Pending
- 1996-02-12 CZ CZ972553A patent/CZ255397A3/cs unknown
- 1996-02-12 IL IL11711396A patent/IL117113A0/xx unknown
- 1996-02-12 CN CN96191901A patent/CN1173897A/zh active Pending
- 1996-02-12 BR BR9606951A patent/BR9606951A/pt not_active Application Discontinuation
- 1996-02-12 CA CA002210538A patent/CA2210538A1/en not_active Abandoned
- 1996-02-12 KR KR1019970705555A patent/KR19980702160A/ko not_active Application Discontinuation
-
1997
- 1997-06-26 FI FI972763A patent/FI972763A/fi unknown
- 1997-08-11 NO NO973679A patent/NO973679L/no unknown
Also Published As
Publication number | Publication date |
---|---|
JPH10509327A (ja) | 1998-09-14 |
FI972763A0 (fi) | 1997-06-26 |
SK109997A3 (en) | 1998-04-08 |
HUP9801681A3 (en) | 2000-10-30 |
KR19980702160A (ko) | 1998-07-15 |
NO973679D0 (no) | 1997-08-11 |
NO973679L (no) | 1997-10-13 |
IL117113A0 (en) | 1996-06-18 |
MX9705757A (es) | 1998-07-31 |
CN1173897A (zh) | 1998-02-18 |
BR9606951A (pt) | 1997-10-28 |
EP0811060A1 (en) | 1997-12-10 |
FI972763A (fi) | 1997-10-10 |
AU4665196A (en) | 1996-09-04 |
CA2210538A1 (en) | 1996-08-22 |
WO1996025492A1 (en) | 1996-08-22 |
CZ255397A3 (cs) | 1998-02-18 |
HUP9801681A2 (hu) | 1998-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9900422A3 (en) | Novel protein and methods for the production of the same | |
AU5893696A (en) | Modification of polypeptides | |
GB9526560D0 (en) | Use of 2-Amino-Heterocycles | |
AU5893796A (en) | Modification of polypeptides | |
IL116924A0 (en) | Preparation of n-aryl- and n-hetarylhydroxylamines | |
GB9510830D0 (en) | Proteins | |
PL321239A1 (en) | Mutations of proteins | |
ZA96725B (en) | Use of phenyclyclohexylcarboxamides | |
HUP9801330A3 (en) | Novel pka-binding proteins and uses thereof | |
IL115317A0 (en) | Proteins | |
AU5284296A (en) | Immune-evading proteins | |
GB9519865D0 (en) | Protein | |
AU6153396A (en) | E6ap-binding proteins | |
IL117786A (en) | Preparation of alpha-bisoximes | |
NZ307236A (en) | Preparation of streptogramins | |
GB9622436D0 (en) | Protein | |
GB9513043D0 (en) | Selection of recombinant molecules | |
GB9509102D0 (en) | Modified proteins | |
GB9524341D0 (en) | Proteins | |
GB9502138D0 (en) | Proteins | |
IL118225A0 (en) | Use of felodipine | |
ZA955497B (en) | Peptide derivatives of alpha-MSH-and their application | |
GB9516227D0 (en) | Re-textured protein | |
GB9501486D0 (en) | Protein | |
GB9522660D0 (en) | Protein |